Jacob Glanville

Jacob Glanville is an Entrepreneur and Computational Immuno-Engineer. As Founder, CEO and President of Centivax, he enjoys collaborating with multiple partners to generate exciting new technologies in biomedicine.

Wednesday
May 07
Universal Immunity
1:45 PM

-

2:15 PM

Imagine a world where infectious diseases can be neutralized before they become global threats—where immunity isn't reactive, but universal. This session explores groundbreaking advancements in biotechnology, rapid-response platforms, and global health strategies that aim to provide immediate protection against emerging pathogens. From engineered antibodies and synthetic vaccines to decentralized diagnostics and equitable healthcare distribution, join the conversation on how science, innovation, and collaboration could revolutionize humanity's defense against the next pandemic.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025